top of page
Search

Our new paper in Advanced Therapeutics

  • Writer: Announcer
    Announcer
  • Jun 12, 2021
  • 1 min read

Updated: Dec 2, 2021

Our work on inhaled powder formulation of tamibarotene, a repurposed drug that exhibits broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV and influenza A H1N1 virus following pulmonary delivery, is accepted for publication in Advanced Therapeutics. This work is in collaboration with Dr. Shuofeng Yuan from the HKU Department of Microbiology.


Congrats to Rachel, Carol, Han Cong, Rico, Zitong and the team!




 
 
 

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
Post: Blog2_Post

Subscribe Form

Thank you for subscribing!

Copyright © 2019 Laboratory of Macromolecular Drug Delivery, UCL.

bottom of page